Carregant...
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/118318
Engineered muscle tissues for disease modeling and drug screening applications
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Animal models have been the main resources for drug discovery and prediction of drugs’ pharmacokinetic responses in the body. However, noticeable drawbacks associated with animal models include high cost, low reproducibility, low physiological similarity to humans, and ethical problems. Engineered tissue models have recently emerged as an alternative or substitute for animal models in drug discovery and testing and disease modeling. In this review, we focus on skeletal muscle and cardiac muscle tissues by first describing their characterization and physiology. Major fabrication technologies (i.e., electrospinning, bioprinting, dielectrophoresis, textile technology, and microfluidics) to make functional muscle tissues are then described. Finally, currently used muscle tissue models in drug screening are reviewed and discussed
Matèries
Matèries (anglès)
Citació
Citació
MOHAMMANDI, Mohammad hossein, OBREGÓN, Raquel, AHADIAN, Samad, RAMON AZCON, Javier, RADISIC, Milica. Engineered muscle tissues for disease modeling and drug screening applications. _Current Pharmaceutical Design_. 2017. Vol. 23, núm. 2991-3004. [consulta: 23 de gener de 2026]. ISSN: 1381-6128. [Disponible a: https://hdl.handle.net/2445/118318]